IBB
iShares Biotechnology ETFNASDAQ
Updated 1 day ago
Coverage limited
$200.02-2.08%
Close Oct 13, 2026
- Market cap
- —
- 1 month
- -2.2%
- 3 months
- +5.3%
- 1 year
- +33.4%
- 52-week range
- $151.32$216.96
- Dividend, last 12 mo
- $0.3399 · 0.17% yield
- Last ex-date
- Sep 15, 2026 · $0.0112
- Short interest
- 11.6M sharessettled Sep 30, 2026 · -5.8% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if IBB is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
98 top institutions tracked
as of 2026-Q2 (filed 2026-09-23)
Last 13F trend: distributing (heavy)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
963 filers reported a long position in IBB for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | $1.3B | 6.9M | -5.3% |
| CITIGROUP INC | $905.4M | 4.8M | -7.1% |
| MORGAN STANLEY | $631.6M | 3.3M | +19.7% |
| BNP PARIBAS FINANCIAL MARKETS | $421.8M | 2.2M | -8.7% |
| TWO SIGMA INVESTMENTS, LP | $302M | 1.6M | +184.7% |
| GOLDMAN SACHS GROUP INC | $223.7M | 1.2M | -7.8% |
| ENVESTNET ASSET MANAGEMENT INC | $213.5M | 1.1M | -8.5% |
| RAYMOND JAMES FINANCIAL INC | $199.8M | 1.1M | +2% |
| WELLS FARGO & COMPANY/MN | $195.8M | 1M | +20.5% |
| COMMERCE BANK | $172.9M | 909.3K | +3.1% |
Get the Full Analysis for IBB
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.